A pricing policy towards the sourcing of cheaper drugs in Cyprus

Health Policy

Volumn 81, Issue 2-3, 2007, Pages 368-375

  Merkur, Sherry ^a   Mossialos, Elias ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Cyprus; Drug importation; Pharmaceutical pricing; Wholesaler incentives

Indexed keywords

ARTICLE; COST CONTROL; CYPRUS; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; EUROPE; GOVERNMENT; HEALTH ECONOMICS;

COMMERCE; COST CONTROL; CYPRUS; DRUG COSTS; EUROPEAN UNION; GREAT BRITAIN; POLICY MAKING; STATE MEDICINE;

EID: 33947198151     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.07.007     Document Type: Article

References (30)

1. Golna C., Pashardes P., Allin S., et al. Health Care Systems in Transition: Cyprus (2004), WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen
2. Mossialos E., Brogan D., and Walley T. Pharmaceutical pricing in Europe: weighing up the options. Int Soc Security Rev 59 3 (2006) 3-25
3. Asplipeios Iatridis. Pharmaceutical prices. I Simerini; 2003, available at http://www.simerini.com.cy/nqcontent.cfm?a_id=84599, accessed August 16, 2003 [in Greek].
4. OECD. Drug spending in OECD countries up by nearly a third since 1998, according to new OECD data (2005), OECD, Paris. http://www.oecd.org/document/25/0,2340,en_2649_201185_34967193_1_1_1_1,00.html available at http://www.oecd.org/document/25/0,2340,en_2649_201185_34967193_1_1_1_1,00.html, accessed August 31, 2005
5. Republic of Cyprus, Ministry of Health. Private pharmaceutical price lists (2004), Department of Pharmaceutical Services, Nicosia
6. Kanavos P., and Gemmill M. Pharmaceutical pricing and reimbursement in Europe (2005), T&F Informa UK Ltd., London
7. Verband Forschender Arzneimittelhersteller (VFA). Statistics 2002: the pharmaceutical industry in Germany (2005). http://www.vfa.de/ available at http://www.vfa.de, accessed September 10, 2005
8. Paris V. Pharmaceutical regulation in France 1980-2003. Int J Health Plann Manage 20 4 (2005) 307-328
9. Lægemiddelindustriforeningen (LiF). Concentration of wholesalers in Europe and the local share of the top 3 (2006), Lif, Denmark. http://www.talogdata.dk/sw280.asp available at http://www.talogdata.dk/sw280.asp, accessed May 9, 2006
10. Taylor D., Mrazek M., and Mossialos E. Regulating pharmaceutical distribution and retail pharmacy in Europe. In: Mossialos E., Mrazek M., and Walley T. (Eds). Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality (2004), Open University Press, London 204
11. Danish Medicines Agency (Lægemiddelstyrelsen). Pharmaceutical price list (2003), Lægemiddelstyrelsen, Copenhagen. http://www.dkma.dk/ available at http://www.dkma.dk/, accessed August 20, 2003
12. Greek Pharmacists' Association. Pharmaceutical price list (2003), Vlasis Varkes and Company, Athens
13. Portuguese Ministry of Economy. Listagem Geral de Precos (2003), Ministério de Economia, Lisbon. http://www.dgcc.pt/ available at http://www.dgcc.pt, accessed January 5, 2004
14. Medicamentos del Nomenclator Español. Todos los medicamentos 2003 (2003), Sir Informatica S.I., Zaragoza. http://www.hipocrates.com/vademe/ available at http://www.hipocrates.com/vademe/, accessed December 18, 2003
15. Apoteket AB. Pristlista (2003), Apoteket AB, Stockholm. http://www.lfn.se/ available at http://www.lfn.se/, accessed December 10, 2003
16. UK MIMS. Monthly index of medical specialties (2003), Haymarket Medical Publications Ltd., Southall
17. UK Department of Health and ABPI. PPRS: the study into the extent of competition in the supply of branded medicines to the NHS (2002), Department of Health, London. http://www.dh.gov.uk/assetRoot/04/06/73/18/04067318.pdf available at http://www.dh.gov.uk/assetRoot/04/06/73/18/04067318.pdf, accessed June 17, 2004
18. Kontozamanis V., Mantzouneas E., and Stoforos C. An overview of the Greek pharmaceutical market. Eur J Health Econ 4 4 (2003) 327-333
19. Oanda. Historical exchange rates. Available at http://www.oanda.com/convert/fxhistory, accessed June 1, 2004.
20. WHO Collaborating Centre for Drug Statistics Methodology. Oslo: Norwegian Institute of Public Health; 2004. Available at http://www.whocc.no/atcddd/, accessed June 1, 2004.
21. Kenney J.F., and Keeping E.S. Mathematics of statistics, Pt. 1. 3rd ed. (1962), Van Nostrand, Princeton NJ pp. 65-67
22. Eurostat. GDP per capita in the EU25 (2005), Eurostat. http://epp.eurostat.cec.eu.int/ available at http://epp.eurostat.cec.eu.int/, accessed January 26, 2005
23. European Parliament. Directive 2004/27/EC of the European Parliament and of the council of March 31, 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, L136/56, point 84 insertion of Article 126a; 2004.
24. Ramsey F. A contribution to the theory of taxation. Econ J 37 1 (1927) 47-61
25. Danzon P.M., and Towse A. Differential pricing for pharmaceuticals: reconciling access, R&D and patents. Int J Healthcare Finance Econ 3 (2003) 183-205
26. Wagner J.L., and McCarthy E. International differences in drug prices. Ann Rev Public Health 25 (2004) 475-495
27. Danzon P.M., and Kim J.D. International price comparisons for pharmaceuticals. Measurement and policy issues. Pharmacoeconomics 14 Suppl 1 (1998) 115-128
28. Kanavos P., and Mossialos E. International comparisons of health care expenditures: what we know and what we do not know. J Health Services Res Policy 4 2 (1999) 122-126
29. Cyprus Association of Pharmaceutical Companies. MOH circular-new pricing policy (2005), CAPC, Nicosia. http://www.capc.org.cy/Circular_to_Importers_english.doc available at http://www.capc.org.cy/Circular_to_Importers_english.doc, accessed June 8, 2005
30. Cyprus Association of Pharmaceutical Companies. Price-list-coming into effect on 01/03/2005 until 28/02/2006 (2005), CAPC, Nicosia. http://www.capc.org.cy/Updated_MOH_Pricelist2005.xls available at http://www.capc.org.cy/Updated_MOH_Pricelist2005.xls, accessed June 8, 2005